PHARMACOKINETICS OF OXAPROZIN

被引:0
|
作者
MILLER, LG
机构
来源
CLINICAL PHARMACY | 1993年 / 12卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [21] SINGLE AND MULTIDOSE PHARMACOKINETICS (PK) OF OXAPROZIN (O) VS PIROXICAM (P) IN HEALTHY-YOUNG AND OSTEOARTHRITIC ELDERLY SUBJECTS
    JAIN, AK
    MCMAHON, FG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 212 - 212
  • [22] THE URICOSURIC EFFECT OF OXAPROZIN IN HUMANS
    GOLDFARB, S
    WALKER, BR
    AGUS, ZS
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (02): : 144 - 148
  • [23] HEPATIC-EFFECTS OF OXAPROZIN
    ZIMMERMAN, HJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1986, 15 (03) : 35 - 39
  • [24] Oxaprozin-induced pseudoporphyria
    Ingrish, G
    Rietschel, RL
    ARCHIVES OF DERMATOLOGY, 1996, 132 (12) : 1519 - 1520
  • [25] TREATMENT OF ACUTE GOUT WITH OXAPROZIN
    MEASE, PJ
    WILLKENS, RF
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1986, 15 (03) : 86 - 89
  • [26] EFFECTS OF FOOD ON OXAPROZIN BIOAVAILABILITY
    CHIANG, ST
    KNOWLES, JA
    HUBSHER, JA
    RUELIUS, HW
    WALKER, BR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (8-9): : 381 - 385
  • [27] OXAPROZIN DISPOSITION IN RENAL-DISEASE
    CHIANG, ST
    MORRISON, G
    KNOWLES, JA
    RUELIUS, HW
    WALKER, BR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) : 509 - 515
  • [28] Oxaprozin-induced symptomatic hepatotoxicity
    Kethu, SR
    Rukkannagari, S
    Lansford, CL
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) : 942 - 944
  • [29] Pharmacological profile of oxaprozin eye drops
    Bucolo, C
    Maltese, A
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2002, 18 (01) : 75 - 81
  • [30] METABOLISM AND KINETICS OF OXAPROZIN IN NORMAL SUBJECTS
    JANSSEN, FW
    JUSKO, WJ
    CHIANG, ST
    KIRKMAN, SK
    SOUTHGATE, PJ
    COLEMAN, AJ
    RUELIUS, HW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) : 352 - 362